Skip to main content

Liquet Medical

Liquet Medical develops the Versus Catheter, a dual-tip infusion device that incorporates real-time pressure monitoring and a flow-directed placement balloon for precise localized drug delivery in vascular disease treatment. This technology addresses the challenges of ineffective systemic drug administration by enhancing targeted therapy, ultimately improving patient outcomes.

Traction 8/10
Glen Allen, United States · HQ
Founded 20206500+ followers
  • Healthcare Technology
  • Medical Devices
Updated 23 months ago

Funding

Raised to date

$20KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Derek Hall

COO

Product

Problem

Systemic drug administration for vascular disease often proves ineffective due to dilution and off-target effects, limiting therapeutic impact and potentially increasing systemic toxicity. Precise localized drug delivery is challenging, requiring accurate placement and real-time monitoring to ensure optimal drug concentration at the target site. Current methods lack the ability to effectively control drug distribution and assess the pressure dynamics during infusion, hindering treatment efficacy.

Solution

Liquet Medical's Versus Catheter is a dual-tip infusion device designed for precise localized drug delivery in vascular disease treatment. The catheter incorporates real-time pressure monitoring and a flow-directed placement balloon to enhance targeted therapy. By providing controlled drug infusion directly at the affected site, the Versus Catheter aims to maximize therapeutic impact while minimizing systemic exposure. The flow-directed balloon facilitates accurate placement within the vasculature, while real-time pressure monitoring allows clinicians to optimize drug delivery parameters. This technology seeks to improve patient outcomes by enabling more effective and targeted treatment of vascular diseases.

Target Audience

The primary target audience includes vascular surgeons, interventional radiologists, and other medical professionals involved in the treatment of vascular diseases.

Features

  • Dual-tip infusion catheter for localized drug delivery.
  • Real-time pressure monitoring to optimize drug infusion parameters.
  • Flow-directed placement balloon for accurate catheter positioning within the vasculature.
This profile is AI-generated and may contain inaccuracies.